CoChat

Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies

Open access
Kantarci, Kejal, Yang, Chunhui, Schneider, Julie A., Senjem, Matthew L., Reyes, Denise A., Lowe, Val J., Barnes, Lisa L., Aggarwal, Neelum T., Bennett, David A., Smith, Glenn E., Petersen, Ronald C., Jack, Clifford R., Boeve, Bradley F. · 2012 · Neurobiology of Aging
Cited by 70

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

The association between antemortem [11C]-Pittsburgh Compound B (PiB) retention and β-amyloid (Aβ) load, Lewy body (LB) and neurofibrillary tangle (NFT) densities were investigated in a pathologically confirmed case of dementia with LB (DLB). 76-year-old man presenting with a clinical diagnosis of DLB had undergone PiB–positron emission tomography (PET), 18F FDG-PET and MRI 18 months before death. The pathologic diagnosis was DLB neocortical-type with low-likelihood of Alzheimer's disease by NIA-Reagan criteria. Sections from regions of interest (ROI) on post-mortem examination were studied. A significant correlation was found between cortical Aβ density and PiB retention in the 17 corresponding ROIs (r=0.899; p<0.0001). Bielschowsky silver stain revealed mostly sparse neocortical neuritic plaques; whereas diffuse plaques were frequent. There was no correlation between LB density and PiB retention (r=0.13; p=0.66); nor between NFT density and PiB retention (r=−0.36; p=0.17). The ROI-based analysis of imaging and histopathological data confirms that PiB uptake on PET is a specific marker for Aβ density, but cannot differentiate neuritic from diffuse amyloid plaques in this case with DLB.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2010.08.007

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 27

  1. Ashburner, 2005, Unified segmentation, Neuroimage, 26, 839, 10.1016/j.neuroimage.2005.02.018 · DOI · Paper page
  2. Bacskai, 2007, With Pittsburgh Compound B Confirmed at Autopsy: A Case Report, Mol. Imaging, 3, 431, 10.1001/archneur.64.3.431 · DOI · Paper page
  3. Boeve, 2009, REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions, Ann. N Y Acad. Sci, 1184, 17
  4. Burack, 2010, In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia, Neurology, 74, 77, 10.1212/WNL.0b013e3181c7da8e · DOI · Paper page
  5. Cairns, 2009, Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report, Arch. Neurol, 66, 1557, 10.1001/archneurol.2009.279 · DOI · Paper page
  6. Dickson, 1997, The pathogenesis of senile plaques, J. Neuropathol. Exp. Neurol, 56, 321, 10.1097/00005072-199704000-00001 · DOI · Paper page
  7. Dickson, 2002, Dementia with Lewy bodies: neuropathology, J. Geriatr. Psychiatry Neurol, 15, 210, 10.1177/089198870201500406 · DOI · Paper page
  8. Edison, 2008, Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography, J. Neurol. Neurosurg. Psychiatry, 79, 1331, 10.1136/jnnp.2007.127878 · DOI · Paper page
  9. Ferman, 2006, Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease, Clin. Neuropsychol, 20, 623, 10.1080/13854040500376831 · DOI · Paper page
  10. Fodero-Tavoletti, 2007, In vitro characterization of Pittsburgh compound B binding to Lewy bodies, J. Neurosci, 27, 10365, 10.1523/JNEUROSCI.0630-07.2007 · DOI · Paper page
  11. Galasko, 1994, Clinical-neuropathological correlations in Alzheimer's disease and related dementias, Arch. Neurol, 51, 888, 10.1001/archneur.1994.00540210060013 · DOI · Paper page
  12. Guillozet, 1997, Butyrylcholinesterase in the life cycle of amyloid plaques, Ann. Neurol, 42, 909, 10.1002/ana.410420613 · DOI · Paper page
  13. Joachim, 1988, Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases, Ann. Neurol, 24, 50, 10.1002/ana.410240110 · DOI · Paper page
  14. Klunk, 2003, The binding of 2-(4′-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component, J. Neurosci, 23, 2086, 10.1523/JNEUROSCI.23-06-02086.2003 · DOI · Paper page
  15. Kokmen, 1987, short test of mental status: description and preliminary results, Mayo Clin. Proc, 62, 281, 10.1016/S0025-6196(12)61905-3 · DOI · Paper page
  16. Lopresti, 2005, Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis, J. Nucl. Med, 46, 1959
  17. Lowe, 2009, Comparison of 18F-FDG and PiB PET in cognitive impairment, J. Nucl. Med, 50, 878, 10.2967/jnumed.108.058529 · DOI · Paper page
  18. Maetzler, 2009, Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics, Neurobiol. Dis, 34, 107, 10.1016/j.nbd.2008.12.008 · DOI · Paper page
  19. Maetzler, 2008, [11C]PIB binding in Parkinson's disease dementia, NeuroImage, 39, 1027, 10.1016/j.neuroimage.2007.09.072 · DOI
  20. McKeith, 2005, Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium, Neurology, 65, 1863, 10.1212/01.wnl.0000187889.17253.b1 · DOI · Paper page
  21. McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  22. Mirra, 1991, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Neurology, 41, 479, 10.1212/WNL.41.4.479 · DOI · Paper page
  23. Mufson, 1988, Neurofibrillary tangles in cholinergic pedunculopontine neurons in Alzheimer's disease, Ann. Neurol, 24, 623, 10.1002/ana.410240506 · DOI
  24. Schneider, 2002, Improved detection of substantia nigra pathology in Alzheimer's disease, J. Histochem. Cytochem, 50, 99, 10.1177/002215540205000111 · DOI · Paper page
  25. Senjem, 2005, Comparisson of different methodological implementations of voxel-based morphometry in neurodegenerative disease, Neuroimage, 26, 370, 10.1016/j.neuroimage.2005.02.005 · DOI · Paper page
  26. Thal, 2006, The role of biomarkers in clinical trials for Alzheimer disease, Alzheimer Dis. Assoc. Disord, 20, 6, 10.1097/01.wad.0000191420.61260.a8 · DOI · Paper page
  27. Zaccai, 2005, systematic review of prevalence and incidence studies of dementia with Lewy bodies, Age Ageing, 34, 561, 10.1093/ageing/afi190 · DOI · Paper page

Cited by

See all 70

Metadata

Authors
Kantarci, K., Yang, C., Schneider, J. A., Senjem, M. L., Reyes, D. A., Lowe, V. J., Barnes, L. L., Aggarwal, N. T., Bennett, D. A., Smith, G. E., Petersen, R. C., Jack, C. R., & Boeve, B. F.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2012-05
Volume
33
Issue
5
Pages
878-885
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2098138468
Cited by
70
References
11
FWCI
4.79
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
Paul B. Beeson Career Development Award in Aging (K23-AG030935, P50-AG16574/Project1, P30-AG010161, RO 1-AG15866, R01-AG11378)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2010.08.007
The paper
Kantarci, K., Yang, C., Schneider, J. A., Senjem, M. L., Reyes, D. A., Lowe, V. J., Barnes, L. L., Aggarwal, N. T., Bennett, D. A., Smith, G. E., Petersen, R. C., Jack, C. R., & Boeve, B. F. (2012). Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2010.08.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.